Stock Analysts

Positive Data on VRTX Combo Therapy (VRTX)

Vertex Pharmaceuticals Inc. ( VRTX ) recently reported positive interim data from two treatment arms (E and F) of a mid-stage study (ZENITH) of VX-222, when dosed in combination with Incivek (telaprevir) and ribavirin in treatment-naïve patients with genotype 1 (1a and 1b) hepatitis C virus (HCV). Each arm (E and F) of the ZENITH study, which consisted of 23 patients, was conducted to determine whether a patient was eligible to stop all treatment at 12 weeks […]

Stock Analysts

Hologic to Exchange Notes (CPHD) (CPTS) (HOLX)

Hologic ( HOLX ) has decided to retire $500 million of its 2% convertible senior notes (due 2037) in exchange of $500 million of 2% convertible senior notes due 2042. Subsequent to this arrangement, $775 million in aggregate principal amount of the original notes will remain outstanding. The new notes have been issued at a conversion rate of 32.07698 shares per $1,000 of principal amount (conversion price of approximately $31.175 per share), which represents a 45% premium over the closing price of Hologic's share on February 28, 2012. […]

Stock Analysts

St. Jude Beefs up Dividend (BSX) (MDT) (STJ)

Medical technology major St. Jude ( STJ ) has bumped up its quarterly dividend to 23 cents a share from 21 cents, representing a 10% hike. This lifts the annual dividend to 92 cents per share from the current payout of 84 cents and equates to a dividend yield of roughly 2.2% […]

Stock Analysts

Bleak Outlook for Dendreon’s Provenge (DNDN) (JNJ) (MDVN) (MRK)

Dendreon Corporation ( DNDN ) reported fourth-quarter 2011 earnings (including stock-based compensation expense but excluding other special items) of 37 cents per share, in contrast to the Zacks Consensus Estimate loss of 31 cents and year-ago loss of 60 cents per share. Full-year loss of $1.68 per share (excluding special items but including stock-based compensation expense) were narrower than the Zacks Consensus Estimate of a loss of $2.83 and the year-ago loss of $3.07 per share. Total revenue in the reported quarter climbed to $202.1 million from $25.0 million in the comparable quarter of 2010. […]

Stock Analysts

Unisys Launches New Services (UIS)

Unisys Corporation ( UIS ) recently announced that the company has launched a new set of services which will supposedly help organizations in executing tasks more efficiently. These tasks help reduce the cost, complexity, risk and time involved in implementing a complex mission-critical application modernization initiative. Unisys added that these new services are known as Application Modernization Platform as a Service (AMPS) COE (Center of Excellence) are designed to help clients maximize return on investment from their modernization initiatives and realize the full benefits of a service-oriented architecture (SOA) […]